VivaLNK Selected for Plug and Play Silicon Valley Health Program, Joins Ranks of PayPal and Google Alumni

VCBeat has learned that VivaLNK, a Silicon Valley-based medical IoT company, has been selected for the Plug and Play Silicon Valley Health Program. VivaLNK was included in the 8th batch of the Plug and Play Silicon Valley Health Program. From a pool of over 850 startups, VivaLNK and 19 other companies stood out to join the Plug and Play innovation platform.

Plug and Play is the world’s earliest high-tech investment accelerator. PNP focuses on helping startup teams achieve rapid growth. Since 1998, PNP has accelerated and invested in more than 6,000 startups, giving rise to billion-dollar unicorns such as PayPal, Google, LendingClub, Dropbox, and Logitech.

To better incubate innovative projects, Plug and Play has established the Plug and Play Innovation Platform. Over the past decade, Plug and Play has developed this platform into a world-class ecosystem that connects startups, growth-stage companies, investors, mentors, and Fortune 500 corporations, providing entrepreneurs with the best opportunities for success. Plug and Play aims to facilitate meaningful introductions and cultivate long-term relationships, delivering value to all parties involved.

Each year, Plug and Play provides a platform over a 12-week period to help startups and growth-stage companies across various industries and stages raise capital, while also partnering with corporations to explore business development opportunities.

Currently, Plug and Play’s innovation platform encompasses 12 vertical markets: Mobility, Supply Chain & Logistics, FinTech, Food, Internet of Things (IoT), Branding & Retail, Health, Travel & Hospitality, Insurance, Energy & Sustainability, New Materials, and Media.

VivaLNK, founded by Dr. Jiang Li, was established as a Category A key-supported enterprise in Hangzhou shortly after its inception through the “5050 Overseas High-Level Talent Entrepreneurship Program.” From the outset, VivaLNK collaborated with Google on an “electronic skin” project. Its flagship medical-grade flexible smart temperature patch has obtained multiple professional certifications, including FDA clearance, CE Medical marking, and TGA approval. In partnership with Reckitt Benckiser, a Fortune 500 company, the product has achieved successful commercialization worldwide.

Next, VivaLNK will leverage its independently developed, disruptive eSkin® medical sensing technology and advanced medical cloud-based AI data analytics capabilities to enable multi-parameter vital signs monitoring and physiological analysis in the Internet of Medical Things (IoMT) space through medical-grade wearable devices. The company is committed to providing its market partners with comprehensive solutions for health management, patient monitoring, and remote care.

Notably, wearable ECG monitors were also included in the “10 Breakthrough Technologies 2019” list released yesterday by MIT Technology Review. This is a sector where VivaLNK has already established its presence.

Other breakthrough technologies include: dexterous robots, a new wave of nuclear energy, preterm birth prediction, intestinal micro-capsules, customized cancer vaccines, lab-grown meat burgers, carbon capture, wearable ECG monitors, sewer-free toilets, and AI assistants capable of fluent conversation.